Projects

A prospective active controlled, randomised, double blind, multicentre phase III study to compare the safety and efficacy of Biosimilar Denosumab of Enzene Biosciences Ltd vs Innovator Denosumab in the treatment of Postmenopausal osteoporosis

Project Duration

2018 - 2018

Project Lead

Dr Joe Joseph Cherian

Authors

Dr. Joe Joseph Cherian

Project Status

completed

Project Type

Phase III